Michels RG, Gass JD (1974) The natural course of retinal branch vein obstruction. Trans Am Acad Ophthalmol Otolaryngol 78:166–177

Google Scholar 

Hayreh SS, Podhajsky PA, Zimmerman MB (2011) Natural history of visual outcome in central retinal vein occlusion. Ophthalmology 118:119–133. https://doi.org/10.1016/j.ophtha.2010.04.019

Article  PubMed  Google Scholar 

Noma H, Yasuda K, Shimura M (2019) Cytokines and the pathogenesis of macular edema in branch retinal vein occlusion. J Ophthalmol 2019:5185128. https://doi.org/10.1155/2019/5185128

Article  PubMed  PubMed Central  CAS  Google Scholar 

Noma H, Yasuda K, Shimura M (2020) Cytokines and pathogenesis of central retinal vein occlusion. J Clin Med 9(11):3457. https://doi.org/10.3390/jcm9113457

Article  PubMed  PubMed Central  CAS  Google Scholar 

Campochiaro PA, Brown DM, Awh CC, Lee SY, Gray S, Saroj N, Murahashi WY, Rubio RG (2011) Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study. Ophthalmology 118:2041–2049. https://doi.org/10.1016/j.ophtha.2011.02.038

Article  PubMed  Google Scholar 

Heier JS, Clark WL, Boyer DS, Brown DM, Vitti R, Berliner AJ, Kazmi H, Ma Y, Stemper B, Zeitz O, Sandbrink R, Haller JA (2014) Intravitreal aflibercept injection for macular edema due to central retinal vein occlusion: two-year results from the COPERNICUS study. Ophthalmology 121:1414-1420e1411. https://doi.org/10.1016/j.ophtha.2014.01.027

Article  PubMed  Google Scholar 

Korobelnik JF, Holz FG, Roider J, Ogura Y, Simader C, Schmidt-Erfurth U, Lorenz K, Honda M, Vitti R, Berliner AJ, Hiemeyer F, Stemper B, Zeitz O, Sandbrink R, GALILEO Study Group (2014) Intravitreal aflibercept injection for macular edema resulting from central retinal vein occlusion: one-year results of the phase 3 GALILEO study. Ophthalmology 121:202–208. https://doi.org/10.1016/j.ophtha.2013.08.012

Article  PubMed  Google Scholar 

Ashraf M, Souka AA, Singh RP (2016) Central retinal vein occlusion: modifying current treatment protocols. Eye (Lond) 30:505–514. https://doi.org/10.1038/eye.2016.10

Article  PubMed  PubMed Central  CAS  Google Scholar 

Shalchi Z, Mahroo O, Bunce C, Mitry D (2013) Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion. Cochrane Database Syst Rev 7:009510. https://doi.org/10.1002/14651858.CD009510.pub3

Article  Google Scholar 

Campochiaro PA, Sophie R, Pearlman J, Brown DM, Boyer DS, Heier JS, Marcus DM, Feiner L, Patel A, RETAIN Study Group (2014) Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN study. Ophthalmology 121:209–219. https://doi.org/10.1016/j.ophtha.2013.08.038

Article  PubMed  Google Scholar 

Spooner K, Fraser-Bell S, Hong T, Chang AA (2019) Five-year outcomes of retinal vein occlusion treated with vascular endothelial growth factor inhibitors. BMJ Open Ophthalmol 4(1):e000249. https://doi.org/10.1136/bmjophth-2018-000249

Article  PubMed  PubMed Central  Google Scholar 

Arai Y, Takahashi H, Inoda S, Sakamoto S, Tan X, Inoue Y, Tominaga S, Kawashima H, Yanagi Y (2020) Efficacy of modified treat-and-extend aflibercept regimen for macular edema due to branch retinal vein occlusion: 1-year prospective study. J Clin Med 9:2360. https://doi.org/10.3390/jcm9082360

Article  PubMed  PubMed Central  CAS  Google Scholar 

Arai Y, Takahashi H, Inoda S, Sakamoto S, Tan X, Inoue Y, Tominaga S, Kawashima H, Yanagi Y (2021) Efficacy of modified treat-and-extend regimen of aflibercept for macular edema from branch retinal vein occlusion: 2-year prospective study outcomes. J Clin Med 10:3162. https://doi.org/10.3390/jcm10143162

Article  PubMed  PubMed Central  Google Scholar 

Scott IU, Ip MS, VanVeldhuisen PC, Oden NL, Blodi BA, Fisher M, Chan CK, Gonzalez VH, Singerman LJ, Tolentino M, The SCORE Study Research Group (2009) A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the Standard Care vs corticosteroid for retinal vein occlusion (SCORE) study report 6. Arch Ophthalmol 127:1115–11128. https://doi.org/10.1001/archophthalmol.2009.233

Article  PubMed  PubMed Central  Google Scholar 

Ip MS, Scott IU, VanVeldhuisen PC, Oden NL, Blodi BA, Fisher M, Singerman LJ, Tolentino M, Chan CK, Gonzalez VH, The SCORE Study Research Group (2009) A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs corticosteroid for retinal vein occlusion (SCORE) study report 5. Arch Ophthalmol 127:1101–1114. https://doi.org/10.1001/archophthalmol.2009.234

Article  PubMed  PubMed Central  Google Scholar 

Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon y-H, Jacques M-L, Jiao J, Li X-Y, Whitcup SM, OZURDEX GENEVA Study Group (2010) Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 117(6):1134-1146e3. https://doi.org/10.1016/j.ophtha.2010.03.032

Article  PubMed  Google Scholar 

Moon J, Kim M, Sagong M (2016) Combination therapy of intravitreal bevacizumab with single simultaneous posterior subtenon triamcinolone acetonide for macular edema due to branch retinal vein occlusion. Eye (Lond) 30(8):1084–1090. https://doi.org/10.1038/eye.2016.96

Article  PubMed  CAS  Google Scholar 

Motarjemizadeh G, Rajabzadeh M, Aidenloo NS, Valizadeh R (2017) Comparison of treatment response to intravitreal injection of triamcinolone, bevacizumab and combined form in patients with central retinal vein occlusion: a randomized clinical trial. Electron Physician 9(8):5068–5074. https://doi.org/10.19082/5068

Article  PubMed  PubMed Central  Google Scholar 

Osaka R, Muraoka Y, Nakano Y, Takasago Y, Koyama Y, Miyoshi Y, Tsujikawa A, Suzuma K (2020) Oneyear results of antivascular endothelial growth factor therapy combined with triamcinolone acetonide for macular edema associated with branch retinal vein occlusion. Jpn J Ophthalmol 64:605–612. https://doi.org/10.1007/s10384-020-00765-w

Article  CAS  Google Scholar 

Cohen I, Rider P, Carmi Y, Braiman A, Dotan S, White MR, Voronov E, Martin MU, Dinarello CA, Apte RN (2010) Differential release of chromatin-bound IL-1alpha discriminates between necrotic and apoptotic cell death by the ability to induce sterile inflammation. Proc Natl Acad Sci USA 107:2574–257920133797. https://doi.org/10.1073/pnas.0915018107

Article  PubMed  PubMed Central  Google Scholar 

Royall JA, Berkow RL, Beckman JS, Cunningham MK, Matalon S, Freeman BA (1989) Tumor necrosis factor and interleukin 1 alpha increase vascular endothelial permeability. Am J Physiol 257:399–410. https://doi.org/10.1152/ajplung.1989.257.6.L399

Article  Google Scholar 

Bucher F, Lee J, Shin S, Kim MS, Oh Y-S, Ha S, Zhang H, Yea K (2018) Interleukin-5 suppresses vascular endothelial growth factor-induced angiogenesis through STAT5 signaling. Cytokine 110:397–403. https://doi.org/10.1016/j.cyto.2018.06.021

Article  PubMed  CAS  Google Scholar 

Maruo N, Morita I, Shirao M, Murota S (1992) IL-6 increases endothelial permeability in vitro. Endocrinology 131(2):710–714. https://doi.org/10.1210/endo.131.2.1639018

Article  PubMed  CAS  Google Scholar 

Noma H, Funatsu H, Yamasaki M, Tsukamoto H, Mimura T, Sone T, Jian K, Sakamoto I, Nakano K, Yamashita H, Minamoto A, Mishima HK (2005) Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalmol 140:256–261. https://doi.org/10.1016/j.ajo.2005.03.003

Article  PubMed  CAS  Google Scholar 

Noma H, Minamoto A, Funatsu H, Tsukamoto H, Nakano K, Yamashita H, Mishima HK (2006) Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 244:309–315. https://doi.org/10.1007/s00417-004-1087-4

Article  PubMed  CAS  Google Scholar 

Noma H, Funatsu H, Yamasaki M, Tsukamoto H, Mimura T, Sone T, Hirayama T, Tamura H, Yamashita H, Minamoto A, Mishima HK (2008) Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion. Eye (Lond) 22(1):42–48. https://doi.org/10.1038/sj.eye.6702498

Article  PubMed  CAS  Google Scholar 

Noma H, Funatsu H, Mimura T, Harino S, Hori S (2009) Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion. Opthalmology 116(1):87–93. https://doi.org/10.1016/j.ophth.2008.09.034

Article  Google Scholar 

Zhu C, Pan L, Yi Q, Wei Q (2022) Analysis of the cytokine expression in the aqueous humor of individuals with BRVO-associated macular edema. J Ophthalmol 2022:1514244.